These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 11121127

  • 1. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
    Li YL, Yu CL, Yu HS.
    J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
    [Abstract] [Full Text] [Related]

  • 2. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
    al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG, Gracie JA, Goudie RB.
    J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
    [Abstract] [Full Text] [Related]

  • 3. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ.
    Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
    [Abstract] [Full Text] [Related]

  • 4. Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo.
    Yu HS, Chang KL, Yu CL, Li HF, Wu MT, Wu CS, Wu CS.
    J Invest Dermatol; 1997 Apr; 108(4):527-9. PubMed ID: 9077486
    [Abstract] [Full Text] [Related]

  • 5. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
    Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK.
    Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
    [Abstract] [Full Text] [Related]

  • 6. Apoptosis of melanocytes in vitiligo results from antibody penetration.
    Ruiz-Argüelles A, Brito GJ, Reyes-Izquierdo P, Pérez-Romano B, Sánchez-Sosa S.
    J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
    [Abstract] [Full Text] [Related]

  • 7. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
    Le Poole IC, Stennett LS, Bonish BK, Dee L, Robinson JK, Hernandez C, Hann SK, Nickoloff BJ.
    Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
    [Abstract] [Full Text] [Related]

  • 8. Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules.
    Hedley SJ, Metcalfe R, Gawkrodger DJ, Weetman AP, Mac Neil S.
    Br J Dermatol; 1998 Dec; 139(6):965-73. PubMed ID: 9990357
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune etiology of generalized vitiligo.
    Le Poole IC, Luiten RM.
    Curr Dir Autoimmun; 2008 Dec; 10():227-43. PubMed ID: 18460889
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical studies from vitiligo--comparison between active and inactive lesions.
    Ahn SK, Choi EH, Lee SH, Won JH, Hann SK, Park YK.
    Yonsei Med J; 1994 Dec; 35(4):404-10. PubMed ID: 7871844
    [Abstract] [Full Text] [Related]

  • 11. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
    Zhu MC, Liu CG, Wang DX, Zhan Z.
    Genet Mol Res; 2015 Dec 07; 14(4):16060-73. PubMed ID: 26662399
    [Abstract] [Full Text] [Related]

  • 12. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
    Chen JP, Li HP, Jin SH, Zhang JT, Li J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct 07; 29(10):2107-8, 2111. PubMed ID: 19861278
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM.
    J Invest Dermatol; 2009 Sep 07; 129(9):2220-32. PubMed ID: 19242513
    [Abstract] [Full Text] [Related]

  • 14. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
    Norris DA, Kissinger RM, Naughton GM, Bystryn JC.
    J Invest Dermatol; 1988 Jun 07; 90(6):783-9. PubMed ID: 3373009
    [Abstract] [Full Text] [Related]

  • 15. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
    Hann SK, Shin HK, Park SH, Reynolds SR, Bystryn JC.
    Yonsei Med J; 1996 Dec 07; 37(6):365-70. PubMed ID: 9048487
    [Abstract] [Full Text] [Related]

  • 16. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
    Kroon MW, Kemp EH, Wind BS, Krebbers G, Bos JD, Gawkrodger DJ, Wolkerstorfer A, van der Veen JP, Luiten RM.
    J Eur Acad Dermatol Venereol; 2013 Sep 07; 27(9):1172-5. PubMed ID: 22404127
    [Abstract] [Full Text] [Related]

  • 17. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
    Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V, Ardigó M, Borroni G, Martinetti M, Badulli C, Necker A, Giachino C.
    J Invest Dermatol; 2001 Aug 07; 117(2):326-32. PubMed ID: 11511311
    [Abstract] [Full Text] [Related]

  • 18. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
    Cui J, Bystryn JC.
    Arch Dermatol; 1995 Mar 07; 131(3):314-8. PubMed ID: 7887661
    [Abstract] [Full Text] [Related]

  • 19. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
    Yu HS, Kao CH, Yu CL.
    J Invest Dermatol; 1993 Jun 07; 100(6):823-8. PubMed ID: 8496622
    [Abstract] [Full Text] [Related]

  • 20. Cytolytic antibodies to melanocytes in vitiligo.
    Cui J, Arita Y, Bystryn JC.
    J Invest Dermatol; 1993 Jun 07; 100(6):812-5. PubMed ID: 8496621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.